Prestige BioPharma Limited (950210.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 388.22B |
| Enterprise Value | 388.22B |
| P/E Ratio | -3.05 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 14.46 |
| Price/Book Ratio | 0.76 |
| Enterprise/Revenue | 15.35 |
| Enterprise/EBITDA | -5.62 |
Fiscal Year
| Fiscal Year | June 30, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -3.83 |
| Operating Margin | -3.68 |
AD
Management Effectiveness
| Return On Assets | -0.12 |
| Return On Equity | -0.23 |
Income Statement
| Revenue | 24.82B |
| Revenue/Share | 419.76 |
| Gross Profit | 0 |
| EBITDA | -92.8B |
| Net Income | -117.64B |
| Diluted EPS | -1,957.58 |
Balance Sheet
| Total Cash | 65.89B |
| Total Cash/Share | 1,096.48 |
| Total Debt | 85.94B |
| Total Debt/Equity | 0.18 |
| Current Ratio | 0.85 |
| Book Value Per Share | 9,341.16 |
Price History
| 52-Week Change | -56.24 |
| 52-Week High | 15,350 |
| 52-Week Low | 4,945 |
| Moving Average 50 Days | 6,153 |
| Moving Average 200 Days | 9,574.8 |
Statistics
| Average Volume | 69,557 |
| Shares Outstanding | 60.1M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
